These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 32332302)

  • 1. 18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer.
    Marafi F; Sasikumar A; Alfeeli M; Thuruthel S
    Clin Nucl Med; 2020 Jun; 45(6):e276-e278. PubMed ID: 32332302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer.
    Liu BL; Hong JJ; Tang K; Lin J; Zheng XW
    Clin Nucl Med; 2021 Jul; 46(7):e355-e357. PubMed ID: 33782286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Recurrence of Prostate Cancer: Initial Results with [
    Giesel FL; Will L; Kesch C; Freitag M; Kremer C; Merkle J; Neels OC; Cardinale J; Hadaschik B; Hohenfellner M; Kopka K; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Apr; 59(4):632-635. PubMed ID: 29419475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-PSMA 1007 Uptake in Brain Metastases From Breast Cancer.
    Marafi F; Sasikumar A; Alfeeli M; Fathallah W
    Clin Nucl Med; 2020 Feb; 45(2):e77-e79. PubMed ID: 31693624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hürthle Cell Thyroid Adenoma Showing Avid Uptake on 18F-PSMA-1007 PET/CT.
    Tang K; Wang Z; Lin J; Zheng X
    Clin Nucl Med; 2020 Mar; 45(3):223-224. PubMed ID: 31876816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.
    Marafi F; Sasikumar A; Fathallah W; Esmail A
    Clin Nucl Med; 2020 Jan; 45(1):e61-e62. PubMed ID: 31162269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraindividual Comparison of
    Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
    J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-PSMA-1007 PET/CT for Initial Staging of Renal Cell Carcinoma in an End-Stage Renal Disease Patient.
    Marafi F; Sasikumar A; Aldaas M; Esmail A
    Clin Nucl Med; 2021 Jan; 46(1):e65-e67. PubMed ID: 33181733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-PSMA 1007 in Suspected Renal Cell Carcinoma.
    Marafi F; Sasikumar A; Al-Terki A; Alfeeli M
    Clin Nucl Med; 2020 May; 45(5):377-378. PubMed ID: 32209880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT.
    Ji X; Wang L; Lin J; Tang K
    Clin Nucl Med; 2022 Jan; 47(1):e74-e76. PubMed ID: 34238806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of
    Soeda F; Watabe T; Naka S; Liu Y; Horitsugi G; Neels OC; Kopka K; Tatsumi M; Shimosegawa E; Giesel FL; Hatazawa J
    J Nucl Med; 2019 Nov; 60(11):1594-1599. PubMed ID: 30902876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007.
    Seifert R; Schafigh D; Bögemann M; Weckesser M; Rahbar K
    Clin Nucl Med; 2019 Jun; 44(6):e394-e395. PubMed ID: 30889005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET/CT.
    Witkowska-Patena E; Budzyńska A; Giżewska A; Dziuk M; Walęcka-Mazur A
    Ann Nucl Med; 2020 Mar; 34(3):192-199. PubMed ID: 31902120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraindividual Comparison of
    Dietlein F; Kobe C; Hohberg M; Zlatopolskiy BD; Krapf P; Endepols H; Täger P; Hammes J; Heidenreich A; Persigehl T; Neumaier B; Drzezga A; Dietlein M
    J Nucl Med; 2020 May; 61(5):729-734. PubMed ID: 31628219
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET.
    Arçay A; Eiber M; Langbein T
    Clin Nucl Med; 2020 Jul; 45(7):561-562. PubMed ID: 32433166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of
    Rahbar K; Afshar-Oromieh A; Seifert R; Wagner S; Schäfers M; Bögemann M; Weckesser M
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2055-2061. PubMed ID: 30027419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
    Panagiotidis E; Paschali A; Giannoula E; Chatzipavlidou V
    Clin Nucl Med; 2019 Jan; 44(1):e46-e48. PubMed ID: 30371591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
    Vatankulu B; Işik G; Kocael P; Kuyumcu S; Ilvan Ş; Sağer S; Halaç M; Türkmen C; Sönmezoğlu K
    Nucl Med Commun; 2016 Dec; 37(12):1273-1281. PubMed ID: 27472037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma.
    Panagiotidis E; Paschali A; Xourgia X; Chatzipavlidou V
    Clin Nucl Med; 2020 Dec; 45(12):960-961. PubMed ID: 33065626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.